SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis
Clinical Lymphoma Myeloma and Leukemia · 2025-01 · 25 (1) · 1-12
DOI: 10.1016/j.clml.2024.06.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025-01. Verfasst von Helen T Chifotides und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Mastocytosis, Systemic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: University of Texas MD Anderson Cancer Center, NIH, AbbVie.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: pbose@mdanderson.org.
Förderung
- University of Texas MD Anderson Cancer Center
- NIH
- AbbVie
- National Cancer Institute
- GlaxoSmithKline
Zitieren
APA
Chifotides, H. T., & Bose, P. (2025). SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis. Clinical Lymphoma Myeloma and Leukemia, 25(1), 1-12. https://doi.org/10.1016/j.clml.2024.06.005
Vancouver
Chifotides HT, Bose P. SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis. Clinical Lymphoma Myeloma and Leukemia. 2025;25(1):1-12. doi:10.1016/j.clml.2024.06.005
BibTeX
@article{Chifotides2025,
author = {Chifotides, Helen T and Bose, Prithviraj},
title = {SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2025},
volume = {25},
number = {1},
pages = {1--12},
doi = {10.1016/j.clml.2024.06.005}
}
EUVIMED